Abstract
In the evaluation of the possible physiological roles of new neurotransmitters or neuromodulators, it is necessary to understand the mechanisms underlying their biosynthesis, release and metabolism, and interactions with their receptors. There is now a considerable amount of information on these aspects with regard to the endogenous opioid peptides, which has recently been reviewed from the basic and clinical points of view (Kosterlitz & McKnight, 1980, 1981). For this reason, it is intended to deal in this paper mainly with those concepts that are important for an understanding of the principles governing the possible physiological functions of the enkephalins and endorphins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akil, H., Richardson, D. E., Barchas, J. D. & Li, C. H. (1978a). Appearance of β-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation. Proc. Nat. Acad. Sci. USA, 75, 5170–5172.
Akil, H., Richardson, D. E., Hughes, J. & Barchas, J. D. (1978b). Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation. Science, 201, 463–465.
Akil, H., Watson, S. J., Barchas, J. D. & Li, C. H. (1979). β-endorphin immunoreactivity in rat and human blood: radioimmunoassay, comparative levels and physiological alterations. Life Sci., 24, 1659–1666.
Akil, H., Watson, S. J., Sullivan, S. & Barchas, J. D. (1978c). Enkephalin-like material in normal human CSF: measurement and levels. Life Sci., 23, 121–126.
Almay, B. G. L., Johansson, F., von Knorring, L., Terenius, L. & Wahlström, A. (1978). Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain, 5, 153–162.
Arndt, J. O. & Freye, E. (1979). Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia. Nature, 277, 399–400.
Atweh, S. F. & Kuhar, M. J. (1977a). Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res., 124, 53–67.
Atweh, S. F. & Kuhar, M. J. (1977b). Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res., 129, 1–12.
Atweh, S. F. & Kuhar, M. J. (1977c). Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res., 134, 393–405.
Austen, B. M., Smyth, D. G. & Snell, C. R. (1977). γ endorphin, a endorphin and Metenkephalin are formed extracellularly from lipotropin C fragment. Nature, 269, 619–621.
Barclay, R. K. & Phillips, M. A. (1978). Inhibition of the enkephalin degradation of leuenkephalin by puromycin. Biochem. Biophys. Res. Commun., 81, 1119–1123.
Beaumont, A., Dell, A., Hughes, J., Malfroy, B. & Morris, H. R. (1980). Studies on possible precursors for the enkephalins. In Endogenous and Exogenous Opiate Agonists and Antagonists, ed. Way, E. L. pp. 209–212. New York: Pergamon Press.
Belenky, G. L. & Holaday, J. W. (1979). The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate. Brain Res., 177, 414–417.
Belluzzi, J. C. & Stein, L. (1977). Enkephalin may mediate euphoria and drive-reduction reward. Nature, 266, 556–558.
Bisset, G. W., Chowdrey, H. S. & Feldberg, W. (1978). Release of vasopressin by enkephalin. Brit. J. Pharmac., 62, 370–371.
Bläsig, J., Bäuerle, U. & Herz, A. (1979). Endorphin-induced hyperthermia: characterization of the exogenously and endogenously induced effects. Naunyn-Schmiedeberg’s Arch. Pharmac., 309, 137–143.
Bolme, P., Fuxe, K., Agnati, L. F., Bradley, R. & Smythies, J. (1978). Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anaesthetized rats. Eur. J. Pharmac., 48, 319–324.
Browne, R. G., Derrington, D. C. & Segal, D. S. (1979). Comparison of opiate- and opioid-peptide-induced immobility. Life Sci., 24, 933–942.
Burbach, J. P. H, Loeber, J. G., Verhoef, J., Wiegant, V. M., de Kloet, E. R. & de Wied, D. (1980). Selective conversion of γ-endorphin into peptides related to γ-and α-endorphin. Nature, 283, 96–97.
Chang, K.-J., Cooper, B. R., Hazum, E. & Cuatrecasas, P. (1979). Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol. Pharmac., 16, 91–104.
Chang, W.-C., Jagannadha Rao, A. & Li, C. H. (1978). Rate of disappearance of human γ-lipotropin and γ-endorphin in adult male rats as estimated by radioimmunoassay. Int. J. Peptide Protein Res., 11, 93–94.
Cicero, T. J., Schainker, B. A. & Meyer, E. R. (1979). Endogenous opioids participate in the regulation of the hypothalamic-pituitary-luteinizing hormone axis and testosterone’s negative feedback control of luteinizing hormone. Endocrinology, 104, 1286–1291.
Clement-Jones, V., Lowry, P. J., Rees, L. H. & Besser, G M. (1980). Met-enkephalin circulates in human plasma. Nature, 283, 295–297.
Corbett, A. D., Sosa, R. P., McKnight, A. T. & Kosterlitz, H. W. (1980). Effects of electrical stimulation on the enkephalins in guinea-pig small intestine. Eur. J. Pharmac., in press.
Csontos, K., Rust, M., Höllt, V., Mahr, W., Kromer, W. & Teschemacher, H. J. (1979). Elevated plasma γ-endorphin levels in pregnant women and their neonates. Life Sci., 25, 835–844.
Cusan, L., Dupont, A., Kledzik, G. S., Labrie, F., Coy, D. H. & Schally, A. V. (1977). Potent prolactin and growth hormone releasing activity of more analogues of met-enkephalin. Nature, 268, 544–547.
Duggan, A. W., Griersmith, B. T., Headley, P. M. & Hall, J. G (1979). Lack of effect by substance P at sites in the substantia gelatinosa where Met-enkephalin reduces the transmission of nociceptive impulses. Neurosci. Lett., 12, 313–317.
Duggan, A. W., Hall, J. G & Headley, P. M. (1977). Enkephalins and dorsal horn neurones of the cat: effects on responses to noxious and innocuous skin stimuli. Brit. J. Pharmac., 61, 399–408.
Dupont, A., Cusan, L., Garon, M., Alvarado-Urbina, G & Labrie, F. (1977). Extremely rapid degradation of [3H]-methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sci., 21, 907–914.
Enjalbert, A., Ruberg, M., Arancia, S., Priam, M. & Kordon, C. (1979). Endogenous opiates block dopamine inhibition of prolactin secretion in vitro. Nature, 280, 595–597.
Faden, A. I. & Holaday, J. W. (1979). Opiate antagonists: a role in the treatment of hypovolemic shock. Science, 205, 317–318.
Firemark, H. M. & Weitzman, R. E. (1979). Effects of γ-endorphin, morphine and naloxone on\ arginine vasopressin secretion and the electroencephalogram. Neuroscience, 4, 1895–1902.
Foley, K. M., Kourides, I. A., Inturrissi, C. E., Kaiko, R. F., Zaroulis, C. G., Posner, J. B., Houde, R. W. & Li, C. H. (1979). γ-endorphin: Analgesic and hormonal effects in humans. Proc. Nat. Acad. Sci. USA, 76, 5377–5381.
Frenk, H., McCarty, B. & Liesbeskind, J. C. (1978). Different brain areas mediate the analgesic and epileptic properties of enkephalin. Science, 200, 335–337.
Gillan, M. G. C., Kosterlitz, H. W. & Paterson, S. J. (1980). Comparison of the binding characteristics of tritiated opiates and opioid peptides. Brit. J. Pharmac., in press.
Goldstein, A. & Hilgard, E. R. (1975). Failure of the opiate antagonist naloxone to modify hypnotic analgesia. Proc. Nat. Acad. Sci. USA. 72, 2041–2043.
Graf, L., Kennessy, A., Patthy, A., Grynbaum, A., Marks, N. & Lajtha, A. (1979). Cathepsin D generates γ-endorphin from γ-endorphin. Arch. Biochem. Biophys., 193, 101–109.
Grandison, L. & Guidotti, A. (1977). Regulation of prolactin release by endogenous opiates. Nature, 270, 357–359.
Grynbaum, A., Kastin, A. J., Coy, D. H. & Marks, N. (1977). Breakdown of enkephalin and endorphin analogs by brain extracts. Brain Res. Bull, 2, 479–484.
Guidotti, A. & Grandison, L. (1978). Participation of hypothalamic endorphins in the control of prolactin release. In The Endorphins, Advances in Biochemical Psychopharmacology. Vol. 18. ed., Costa, E. & Trabucchi, M., pp. 191–198. New York: Raven Press.
Guyon, A., Roques, B. P., Guyon, F., Foucault, A., Perdrisot, R., Swerts, J.-P. & Schwartz, J.-C. (1979). Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxypeptidase. Life Sci., 25, 1605–1612.
Hambrook, J. M., Morgan, B. A., Ranee, M. J. & Smith, C. F. C. (1976). Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature, 262, 782–783.
Hayes, R. L., Bennett, G. J., Newlon, P. G. & Mayer, D. J. (1978). Behavioral and physiological studies of non-narcotic analgesia in the rat elicited by certain environmental stimuli. Brain Res., 155, 69–90.
Henderson, G., Hughes, J. & Kosterlitz, H. W. (1978). In vitro release of leu- and met-enkephalin from the corpus striatum. Nature,271, 677–679.
Henriksen, S. J., Bloom, F. E., McCoy, F., Ling, N. & Guillemin, R. (1978). γ-endorphin induces nonconvulsive limbic seizures. Proc. Nat. Acad. Sci. USA, 75, 5221–5225.
Hiller, J. M., Pearson, J. & Simon, E. J. (1973). Distribution of stereo-specific binding of the potent narcotic analgesic etorphine in the human brain: Predominance in the limbic system. Res. Commun, chem. Pathol. Pharmac., 6, 1052–1062.
Hökfelt, T., Ljungdahl, A., Terenius, L., Elade, R. & Nilsson, G. (1977). Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: Enkephalin and substance P. Proc. Nat. Acad. Sci. USA, 74, 3081–3085.
Holaday, J. W. & Faden, A. I. (1978). Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature., 275, 450–451.
Holaday, J. W. & Faden, A. I. (1980). Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res., 189, 295–299.
Höllt, V., Müller, O. A. & Fahlbusch, R. (1979). γ-endorphin in human plasma: basal and pathologically elevated levels. Life Sci, 25, 37–44.
Hosobuchi, Y., Rossier, J., Bloom, F. E. & Guillemin, R. (1979). Stimulation of human periaqueductal gray for pain relief increases immunoreactive γ-endorphin in ventricular fluid. Science, 203, 279–281.
Hutchinson, M., Kosterlitz, H. W., Leslie, F. M., Waterfield, A. A. & Terenius, L. (1975). Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Brit. J. Pharmac., 55, 541–546.
Iversen, L. L., Iversen, S. D., Bloom, F. E., Vargo, T. & Guillemin, R. (1978). Release of enkephalin from rat globus pallidus in vitro. Nature, 271, 679–681.
Janowsky, D., Judd, L., Huey, L., Roitman, N. & Parker, D. (1979). Naloxone effects on serum growth hormone and prolactin in man. Psychopharmac., 65, 95–97.
Jessell, T. M. & Iversen, L. L. (1977). Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature, 268, 549–551.
Kimura, S., Lewis, R. V., Stern, A. S., Rossier, J., Stein, S. & Udenfriend, S. (1980). Probable precursors of [Leu]enkephalin and [Met]enkephalin in adrenal medulla: Peptides of 3–5 kilodaltons. Proc. Nat. Acad. Sci. USA, 77, 1681–1685.
Knight, M. & Klee, W. A. (1978). The relationship between enkephalin degradation and opiate receptor occupancy. J. biol. Chem., 253, 3843–3847.
Kosterlitz, H. W., Lord, J. A. H., Paterson, S. J. & Waterfield, A. A. (1980). Effects of changes in the structure of enkephalins and narcotic analgesic drugs on their interactions with μ-receptors and δ-receptors. Brit. J. Pharmac., 68, 333–342.
Kosterlitz, H. W. & McKnight, A. T. (1980). Modulatory effects of opioid peptides on neurophysiological functions. In Progress in Sensory Physiology, ed., Ottoson, D. Berlin: Springer, in press.
Kosterlitz, H. W. & McKnight, A. T. (1981). Endorphins and enkephalins. In Advances in Internal Medicine, Vol. 26, ed., Siperstein, M. D. & Stollerman, G. H. Chicago: Year Book Medical Publishers, in press.
Kuhar, M. J., Pert, C. B. & Snyder, S. H. (1973). Regional distribution of opiate receptor binding in monkey and human brain. Nature, 245, 447–450.
Lawson, E. E., Waldrop, T. G. & Eldridge, F. C. (1979). Naloxone enhances respiratory output in cats. J. appl. Physiol, 47, 1105–1111.
Lemaire, I., Tseng, R. & Lemaire, S. (1978). Systemic administration of γ-endorphin: Potent hypotensive effect involving a serotonergic pathway. Proc. Nat. Acad. Sci. USA, 75, 6240–6242.
Levine, J. D., Gordon, N. C., Bornstein, J. C. & Fields, H. L. (1979). Role of pain in placebo analgesia. Proc. Nat. Acad. Sci. USA, 76, 3528–3531.
Lewis, R. V., Stein, S., Gerber, L. D., Rubinstein, M. & Udenfriend, S. (1979a). High molecular weight opioid containing proteins in striatum. Proc. Nat. Acad. Sci. USA, 75, 4021–4023.
Lewis, R. V., Stern, A. S., Rossier, J., Stein, S. & Udenfriend, S. (1979b). Putative enkephalin precursors in bovine and renal medulla. Biochem. Biophys. Res. Commun., 89, 822–829.
Lindblom, U. & Tegnér, R. (1979). Are the endorphins active in clinical pain stress? Narcotic antagonism in chronic pain patients. Pain, 7, 65–68.
Liotta, A. S., Gildersleeve, D., Brownstein, M. J. & Krieger, D. T. (1979). Biosynthesis in vitro of immunoreactive 31, 000 dalton corticotropin/γ-endorphin-like material by bovine hypothalamus. Proc. Nat. Acad. Sci. USA, 76, 1448–1452.
Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. W. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature, 267, 495–499.
Lundberg, J. M., Hökfelt, T., Fahrenkrug, J., Nilsson, G. & Terenius, L. (1979). Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immuno-reactivity. Acta physiol. Scand., 107, 279–281.
McKnight, A. T., Hughes, J. & Kosterlitz, H. W. (1979). Synthesis of enkephalins by guinea-pig striatum in vitro. Proc. Roy. Soc. Lond. B, 205, 199–207.
McKnight, A. T., Sosa, R. P., Corbett, A. D. & Kosterlitz, H. W. (1980). Enkephalin precursors from guinea-pig myenteric plexus. In Endogenous and Exogenous Opiate Agonists and Antagonists, ed. Way, E. L. pp. 213–216. New York: Pergamon Press.
McKnight, A. T., Sosa, R. P., Hughes, J. & Kosterlitz, H. W. (1978). Biosynthesis and release of enkephalins. In Characteristics and Function of Opioids. Developments in Neuroscience. Vol. 4. ed. van Ree, J. M. & Terenius, L., pp. 259–269. Amsterdam: Elsevier/North Holland Biomedical Press.
Mains, R. E. & Eipper, B. A. (1978). Coordinate synthesis of corticotropins and endorphins by mouse pituitary tumour cells. J. biol. Chem., 253, 651–655.
Malfroy, B., Swerts, J. P., Guyon, A., Roques, B. P. & Schwartz, J. C. (1978). High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature, 276, 523–526.
Malfroy, B., Swerts, J.-P., Llorens, C. & Schwartz, J.-C. (1979). Regional distribution of a high affinity enkephalin-degrading peptidase (“enkephalinase”) and effects of lesions suggest localization in the vicinity of opiate receptors in brain. Neurosci. Lett., 11, 329–334.
Marks, N., Grynbaum, A. & Neidle, A. (1977). On the degradation of enkephalins and endorphins by rat and mouse brain extracts. Biochem. Biophvs. Res. Commun., 74, 1552–1559.
Martin, J. B., Tolis, G., Woods, I. & Guyda, H. (1979). Failure of naloxone to influence physiological growth hormone and prolactin secretion. Brain Res., 168, 210–215.
Martin, W. R. (1967). Opioid antagonists. Pharmac. Rev., 19, 463–521.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert, P. E. (1976). The effects of morphine- and naloxone-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmac. exp. Ther., 197, 517–532.
Mayer, D. J. (1979). Endogenous analgesia systems: neural and behavioural mechanisms. In Advances in Pain Research and Therapy. Vol. 3, ed. Bonica, J. J., Liebeskind, J. C. & Albe-Fessard, D. G., pp. 385–410. New York: Raven Press.
Mayer, D. J., Price, D. D. & Rafii, A. (1977). Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Res., 121, 368–372.
Meek, J. L., Yang, H.-Y. T. & Costa, E. (1977). Enkephalin catabolism in vitro and in vivo. Neuropharmac., 16, 151–154.
Mello, N. K. & Mendelson, J. H. (1978). Self-administration of an enkephalin analog by rhesus monkeys. Pharmac. Biochem. Behav., 9, 579–586.
Mendelson, J. H., Ellingboe, J., Keuhule, J. C. & Mello, N. K. (1979). Effects of naltrexone on mood and neuroendocrine function in normal male adults. Psychoneuroendocrinology, 3, 231–236.
Nakai, Y., Nakao, K., Oki, S., Imura, H. & Li, C. H. (1978). Presence of immunoreactive γ-endorphin in plasma of patients with Nelson’s syndrome and Addison’s disease. Life Sci, 23, 2293–2298.
Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., Chang, A. C. Y., Cohen, S. N. & Numa, S. (1979). Nucleotide sequence of cloned cDNA for bovine corticotropin-γ-lipotropin precursor. Nature, 278, 423–427
Osborne, H., Höllt, V. & Herz, A. (1978). Potassium-induced release of enkephalins from rat striatal slices. Eur. J. Pharmac., 48, 219–221.
Oyama, T., Jin, T., Yamaya, R., Ling, N. & Guillemin, R. (1980). Profound analgesic effects of γ-endorphin in man. Lancet, 1, 122–124.
Pert, C. B. & Taylor, D. (1980). Type 1 and Type 2 opiate receptors: a subclassification scheme based upon GTP’s differential effects on binding. In Endogenous and Exogenous Opiate Agonists and Antagonists, ed. Way, E. L. pp. 87–90. New York: Pergamon Press.
Pezalla, P. D., Seidah, N. G., Benjannet, S., Crine, P., Lis, M. & Chrétien, M. (1978). Biosynthesis of beta-endorphin, beta-lipotropin and the putative ACTH-LPH precursor in the frog pars intermedia. Life Sci, 23, 2281–2292.
Rivier, C., Vale, W., Ling, N., Brown, M. & Guillemin, R. (1977). Stimulation in vivo of the secretion of prolactin and growth hormone by γ-endorphin. Endocrinology, 100, 238–240.
Roemer, D., Buescher, H. H., Hill, R. C., Pless, J., Bauer, W., Cardinaux, F., Closse, A., Hauser, D. & Huguenin, R. (1977). A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity. Nature, 268, 547–549.
Rossier, J., Lewis, R. V., Stern, A. S., Stein, S. & Udenfriend, S. (1979). Bovine adrenals contain high levels of enkephalins and even higher levels of several putative enkephalin precursors. Abs. Soc. Neuroscience, 5, 538.
Schultzberg, M., Hökfelt, T., Lundberg, J. M., Terenius, L., Elfvin, L.-G. & Elde, R. (1978). Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary gland cells. Acta physiol. Scand., 103, 475–477.
Shaar, C. J., Frederickson, R. C. A., Dininger, N. B. & Jackson, L. (1977). Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin — evidence forregulation by an endogenous opioid peptide in brain. Life Sci, 21, 853–860.
Sjölund, B., Terenius, L. & Eriksson, M. (1977). Increased cerebrospinal fluid levels of ndorphins after electroacupuncture. Acta physiol. Scand., 100, 382–384.
Smith, T. W., Hughes, J., Kosterlitz, H. W. & Sosa, R. P. (1976). Enkephalins: isolation, istribution and function. In Opiates and Endogenous Opioid Peptides, ed. Kosterlitz, H. W. pp. 57–62. Amsterdam: Elsevier/North Holland Biomedical Press.
Sosa, R. P., McKnight, A. T., Hughes, J. & Kosterlitz, H. W. (1977). Incorporation of labelled amino acids into the enkephalins. FEBS Lett., 84, 195–198.
Stacher, G., Bauer, P., Steinringer, H., Schreiber, E. & Schmierer, G. (1979). Effects of the synthetic enkephalin analogue FK 33–824 on pain threshold and pain tolerance in man. Pain, 7, 159–172.
Stein, L. & Belluzzi, J. D. (1979). Brain endorphins: possible mediators of pleasurable states. In Endorphins in Mental Health Research, ed. Usdin, E., Bunney, W. E. & Kline, N. S. pp. 375–389. London: Macmillan Press.
Suda, T., Liotta, A. S. & Krieger, D. T. (1978). γ-endorphin is not detectable in plasma from normal human subjects. Science, 202, 221–223.
Sullivan, S., Akil, H. & Barchas, J. C. (1979). In vitro degradation of enkephalin: evidence for cleavage of the Gly-Phe bond. Commun. Psychopharmac., 2, 525–531.
Székely, J. I., Rónai, A. Z., Dunai-Kovács, Z., Miglécz, E., Berzétei, I., Bajusz, S. & Gráf, L. (1977). (D-Met2, Pro5)-Enkephalinamide: a potent morphine-like analgesic. Eur. J. Pharmac., 43, 293–294.
Urca, G., Frenk, H., Liebeskind, J. C. & Taylor, A. N. (1977). Morphine and enkephalin: analgesic and epileptic properties. Science, 197, 83–86.
Viveros, O. H., Diliberto, E. J., Hazum, E. & Chang, K.-J. (1979). Met- and leu-enkephalins and met-enkephalin-like peptides in the adrenal medulla: studies on storage, secretion and synthesis. Abs. Soc. Neuroscience, 5, 543.
Vogel, Z. & Alstein, M. (1977). The adsorption of enkephalin to porous polystyrene beads: a simple assay for enkephalin hydrolysis. FEBS Lett, 80, 332–336.
von Knorring, L., Almay, B. G. L., Johansson, F. & Terenius, L. (1978). Pain perception and endorphin levels in cerebrospinal fluid. Pain, 5, 359–365.
Walker, J. M., Sandman, C. A., Berntson, G. G., McGivern, R. F., Coy, D. H. & Kastin, A. J. (1977). Endorphin analogs with potent and long-lasting analgesic effects. Pharmac. Biochem. Behav., 7, 543–548.
Watson, S. J., Akil, H., Berger, P. A. & Barchas, J. D. (1979). Some observations on the opiate peptides and schizophrenia. J. gen. Psychiat., 36, 35–41.
Yang, H.-Y. T., Costa, E., Di Giulio, A. M., Fratta, W. & Hong, J. S. (1979). Met-enkephalin (ME)-like peptides in bovine adrenal gland: characterization of possible ME precursors. Fed. Proc., 38, Abs. 711.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1980 The contributors
About this chapter
Cite this chapter
Kosterlitz, H.W. (1980). Possible Physiological Roles of the Enkephalins and Endorphins. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-349-05952-2_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-05954-6
Online ISBN: 978-1-349-05952-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)